The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...

Pfizer (PFE), and Eli Lilly (LLY) traded in the green Monday morning despite declining in pre-market hours after President Donald Trump signed a new executive order that will push drugmakers to sell ...

Eli Lilly (NYSE:LLY ... The latest executive order on drug prices by President Donald Trump has only added to its woes, or has it? The order signed on May 12 aims to align U.S. drug prices ...

The Trump administration is targeting pharmaceutical companies with an executive order aimed at lowering U.S. drug prices ...

US President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details ...

The U.S. imports more pharmaceutical products from Ireland than from any other country -- nearly $50 billion last year. It won't be surprising if the Trump administration especially targets those ...

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

The president said his executive order will require pharmaceutical companies to price drugs in the U.S. in line with the ...

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...